Chemicals · Founded 1989 · www.cmrlindia.com · BSE 513353 · · ISIN INE105D01013
No Notes Added Yet
Business
Cochin Minerals & Rutile Ltd. (CMRL) is an Indian chemical company primarily engaged in the manufacturing of titanium dioxide pigment and other value-added products from ilmenite, a titanium-bearing mineral. Its core business involves processing ilmenite to produce Synthetic Rutile, which is an upgraded form of ilmenite used as a raw material for titanium dioxide pigment and titanium metal. The company also produces Titanium Dioxide (TiO2) pigment, primarily for the paint, plastics, paper, and rubber industries. Additionally, CMRL manufactures co-products such as Ferric Chloride, Ferrous Chloride, and various rare earth minerals (e.g., Zircon, Sillimanite) obtained during the beneficiation process. The company makes money by selling these processed minerals and chemical products to industrial customers both domestically and internationally.
Revenue Mix
CMRL's primary revenue streams are derived from:
Synthetic Rutile: An upgraded titanium ore used as a feedstock for titanium dioxide pigment.
Titanium Dioxide (TiO2) Pigment: White pigment widely used in paints, plastics, paper, and coatings.
Ferric Chloride: Used in water treatment, sewage treatment, and as an etchant in electronics.
Other Co-products: Including Ferrous Chloride and minerals like Zircon and Sillimanite, which are by-products of their processing operations.
The majority of revenue is typically generated from the sale of Synthetic Rutile and Titanium Dioxide pigment. Specific percentage breakdowns are not consistently disclosed publicly but these represent the core product lines.
Industry
CMRL operates within the global chemicals sector, specifically in the titanium minerals and pigments industry. This industry is characterized by its capital-intensive nature, dependence on raw material availability (ilmenite, rutile), and demand fluctuations driven by end-user industries like construction, automotive, and consumer goods. Globally, the titanium dioxide market is dominated by a few large players. In India, CMRL is one of the significant players involved in value addition from ilmenite, producing both synthetic rutile and finished TiO2 pigment. Its positioning is as an integrated producer, converting raw minerals into higher-value chemicals.
MOAT
CMRL's competitive advantages primarily stem from:
Process Know-how: Expertise in the beneficiation of ilmenite and the manufacturing of titanium dioxide pigment, developed over decades.
Integrated Operations: Ability to process raw ilmenite into synthetic rutile and further into titanium dioxide pigment, potentially offering cost efficiencies and quality control.
Raw Material Access: Proximity to abundant ilmenite deposits in the Kerala region, providing a relatively stable supply chain for its primary feedstock.
Established Market Presence: A long-standing history and established customer base in the Indian market, particularly for its specialized products.
Growth Drivers
Increasing Demand for TiO2: Growing demand from end-user industries such as paints & coatings, plastics, paper, and ceramics, especially in emerging economies.
Capacity Expansion: Potential expansion of existing capacities for Synthetic Rutile and Titanium Dioxide to meet rising market demand.
Focus on Value-Added Products: Continuous efforts to enhance product quality and diversify into higher-margin, specialized grades of TiO2 or other chemicals.
Export Opportunities: Leveraging global demand for titanium minerals and pigments, especially if domestic consumption slows or global prices are favorable.
Risks
Commodity Price Volatility: Prices of both raw materials (ilmenite, energy) and finished products (Synthetic Rutile, TiO2 pigment) are subject to global commodity cycles, impacting profitability.
Environmental Regulations: Strict environmental compliance requirements and potential changes in regulations can lead to increased operational costs or capital expenditure.
Operational Risks: Dependency on continuous and efficient plant operations, and potential disruptions due to equipment failure, labor issues, or natural calamities.
Competition: Intense competition from both domestic and international players, including large global chemical conglomerates, can put pressure on pricing and market share.
Demand Fluctuations: Economic downturns or slowdowns in key end-user industries (e.g., construction, automotive) can negatively impact demand for CMRL's products.
Management & Ownership
Cochin Minerals & Rutile Ltd. is a publicly listed company in India. Its promoters include Kerala State Industrial Development Corporation (KSIDC) and Kerala Metals and Minerals Ltd. (KMML), which itself is a Government of Kerala undertaking. This indicates a degree of state-level influence and oversight in its governance. The management team typically comprises experienced professionals from the chemical industry, responsible for steering the company's operations and strategic direction under the guidance of its board.
Outlook
Cochin Minerals & Rutile Ltd. operates in a crucial segment of the chemical industry, benefiting from the fundamental demand for titanium dioxide in various applications. The outlook is balanced by potential growth opportunities from increasing global and domestic consumption of paints, plastics, and other industrial products, alongside CMRL's integrated operations and established market position. However, this is counterbalanced by inherent risks associated with the commodity nature of its products, including price volatility for both raw materials and finished goods, intense competition, and the necessity to adhere to stringent environmental regulations. Sustained profitability will depend on the company's ability to manage costs, optimize production, innovate, and navigate the cyclical nature of the global chemical and mineral markets.
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 101 | 88 | 89 | 65 | 75 | 76 | 65 | 62 | 86 | 131 |
| Other Income | 0 | 1 | 2 | 2 | 5 | 1 | 2 | 2 | 3 | 2 |
| Total Income | 101 | 89 | 91 | 67 | 80 | 78 | 68 | 64 | 88 | 133 |
| Total Expenditure | 84 | 80 | 79 | 59 | 71 | 72 | 63 | 58 | 78 | 116 |
| Operating Profit | 17 | 9 | 12 | 8 | 9 | 5 | 4 | 6 | 10 | 17 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5 | 0 |
| Profit Before Tax | 17 | 9 | 12 | 8 | 9 | 5 | 4 | 5 | 5 | 17 |
| Provision for Tax | 23 | 3 | 5 | 3 | 3 | 2 | 1 | 2 | 1 | 4 |
| Profit After Tax | -7 | 6 | 7 | 5 | 6 | 3 | 3 | 3 | 3 | 12 |
| Adjustments | 0 | 0 | -0 | -0 | 0 | 0 | -0 | -0 | 0 | 0 |
| Profit After Adjustments | -7 | 6 | 7 | 5 | 6 | 3 | 3 | 3 | 3 | 12 |
| Adjusted Earnings Per Share | -8.8 | 7.6 | 9 | 6.4 | 7.1 | 4.2 | 3.8 | 3.8 | 4.2 | 15.8 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 116 | 158 | 149 | 164 | 223 | 263 | 239 | 290 | 444 | 300 | 319 | 344 |
| Other Income | 0 | 0 | 1 | 1 | 2 | 1 | 0 | 0 | 4 | 3 | 8 | 9 |
| Total Income | 116 | 159 | 149 | 165 | 225 | 265 | 239 | 290 | 448 | 303 | 327 | 353 |
| Total Expenditure | 137 | 171 | 149 | 155 | 208 | 241 | 219 | 281 | 372 | 262 | 288 | 315 |
| Operating Profit | -21 | -13 | 0 | 10 | 18 | 23 | 21 | 9 | 76 | 42 | 40 | 37 |
| Interest | 8 | 6 | 7 | 7 | 6 | 3 | 2 | 1 | 2 | 2 | 1 | 0 |
| Depreciation | 4 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5 |
| Profit Before Tax | -33 | -21 | -8 | 2 | 11 | 20 | 18 | 8 | 73 | 39 | 38 | 31 |
| Provision for Tax | -11 | -7 | -2 | 1 | 6 | 14 | 10 | 1 | 17 | 30 | 14 | 8 |
| Profit After Tax | -22 | -14 | -6 | 1 | 5 | 6 | 8 | 6 | 56 | 9 | 24 | 21 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | -22 | -14 | -6 | 1 | 5 | 6 | 8 | 6 | 56 | 9 | 24 | 21 |
| Adjusted Earnings Per Share | -27.5 | -17.9 | -7.3 | 1.7 | 7 | 7.6 | 10.4 | 7.9 | 72.1 | 11 | 30.1 | 27.6 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 6% | 3% | 4% | 11% |
| Operating Profit CAGR | -5% | 64% | 12% | 0% |
| PAT CAGR | 167% | 59% | 32% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -4% | 2% | 17% | 9% |
| ROE Average | 15% | 23% | 17% | 5% |
| ROCE Average | 23% | 37% | 29% | 15% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 86 | 72 | 67 | 68 | 73 | 77 | 85 | 92 | 146 | 148 | 165 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 21 | 15 | 10 | 5 | 0 | 0 | 0 | 0 | 3 | 3 | 0 |
| Other Non-Current Liabilities | -12 | -19 | -21 | -20 | -16 | -6 | 2 | 2 | 4 | 5 | 5 |
| Total Current Liabilities | 59 | 72 | 51 | 85 | 82 | 75 | 28 | 84 | 41 | 95 | 106 |
| Total Liabilities | 154 | 140 | 108 | 138 | 139 | 146 | 116 | 178 | 194 | 251 | 277 |
| Fixed Assets | 17 | 16 | 17 | 14 | 14 | 18 | 18 | 17 | 17 | 17 | 18 |
| Other Non-Current Assets | 31 | 31 | 30 | 29 | 28 | 24 | 24 | 24 | 25 | 25 | 26 |
| Total Current Assets | 106 | 94 | 61 | 96 | 97 | 104 | 74 | 137 | 153 | 208 | 234 |
| Total Assets | 154 | 140 | 108 | 138 | 139 | 146 | 116 | 178 | 194 | 251 | 277 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 27 | 1 | 0 | 0 | 0 | 4 | 4 | 1 | 0 | 0 | 0 |
| Cash Flow from Operating Activities | -3 | 6 | 13 | 9 | 13 | 36 | -9 | 8 | -4 | 6 | 1 |
| Cash Flow from Investing Activities | -4 | -1 | -1 | 4 | -3 | -1 | -1 | -0 | 1 | 0 | 0 |
| Cash Flow from Financing Activities | -19 | -5 | -12 | -13 | -5 | -36 | 7 | -9 | 2 | -6 | -1 |
| Net Cash Inflow / Outflow | -27 | -0 | -0 | -0 | 4 | -1 | -2 | -1 | -0 | -0 | 0 |
| Closing Cash & Cash Equivalent | 1 | 0 | 0 | 0 | 4 | 4 | 1 | 0 | 0 | 0 | 0 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | -27.47 | -17.93 | -7.31 | 1.71 | 6.99 | 7.65 | 10.36 | 7.93 | 72.07 | 10.98 | 30.09 |
| CEPS(Rs) | -22.41 | -15.42 | -6.16 | 2.59 | 7.65 | 8.37 | 11.84 | 9.24 | 73.26 | 12.07 | 31.54 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 1.5 | 8 | 8 | 8 |
| Book NAV/Share(Rs) | 110.18 | 92.25 | 85.73 | 86.63 | 93.55 | 98.71 | 109.04 | 116.92 | 186.85 | 189.58 | 211.23 |
| Core EBITDA Margin(%) | -18.03 | -8.37 | -0.33 | 5.51 | 7.02 | 8.44 | 8.53 | 3.12 | 16.3 | 12.87 | 9.81 |
| EBIT Margin(%) | -20.95 | -9.38 | -0.56 | 5.69 | 7.66 | 8.71 | 8.14 | 2.91 | 16.96 | 13.53 | 12.07 |
| Pre Tax Margin(%) | -27.65 | -13.42 | -5.39 | 1.33 | 5.01 | 7.52 | 7.37 | 2.61 | 16.53 | 13 | 11.83 |
| PAT Margin (%) | -18.09 | -8.84 | -3.84 | 0.82 | 2.45 | 2.27 | 3.39 | 2.14 | 12.71 | 2.86 | 7.38 |
| Cash Profit Margin (%) | -14.76 | -7.6 | -3.24 | 1.23 | 2.68 | 2.49 | 3.88 | 2.5 | 12.92 | 3.15 | 7.74 |
| ROA(%) | -12.18 | -9.55 | -4.61 | 1.09 | 3.94 | 4.2 | 6.19 | 4.22 | 30.27 | 3.86 | 8.92 |
| ROE(%) | -21.95 | -17.71 | -8.22 | 1.98 | 7.75 | 7.95 | 9.97 | 7.02 | 47.45 | 5.83 | 15.01 |
| ROCE(%) | -16.08 | -11.43 | -0.71 | 8.51 | 15.72 | 24.3 | 22.69 | 9.08 | 61.97 | 26.63 | 23.32 |
| Receivable days | 46.31 | 23.67 | 20.21 | 24.66 | 17.4 | 15.78 | 31.67 | 35.04 | 22.26 | 36.12 | 29.56 |
| Inventory Days | 273.98 | 184.84 | 143.18 | 123.41 | 114.15 | 93.12 | 68.14 | 48.19 | 36.08 | 91.69 | 160.46 |
| Payable days | 128.23 | 118.03 | 109.47 | 116.26 | 104.54 | 139.45 | 137.97 | 107.96 | 77.35 | 123.56 | 177.85 |
| PER(x) | 0 | 0 | 0 | 59.08 | 26.73 | 12.71 | 11.05 | 13.36 | 3.81 | 24.52 | 8.48 |
| Price/Book(x) | 0.7 | 0.74 | 1.21 | 1.17 | 2 | 0.98 | 1.05 | 0.91 | 1.47 | 1.42 | 1.21 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 2.06 | 0 | 1.42 | 2.92 | 2.97 | 3.14 |
| EV/Net Sales(x) | 0.93 | 0.64 | 0.84 | 0.71 | 0.79 | 0.26 | 0.41 | 0.2 | 0.38 | 0.65 | 0.57 |
| EV/Core EBITDA(x) | -5.13 | -7.82 | 2075.88 | 11.65 | 10 | 2.96 | 4.7 | 6.11 | 2.22 | 4.67 | 4.61 |
| Net Sales Growth(%) | -11.75 | 36.54 | -5.83 | 10.09 | 36.26 | 17.84 | -9.16 | 21.16 | 53.2 | -32.32 | 6.2 |
| EBIT Growth(%) | -1900.84 | 40.18 | 94.35 | 1208.82 | 83.28 | 33.99 | -15.12 | -56.61 | 791.96 | -45.99 | -5.26 |
| PAT Growth(%) | -454.42 | 34.72 | 59.21 | 123.38 | 308.39 | 9.46 | 35.45 | -23.41 | 808.52 | -84.77 | 174.11 |
| EPS Growth(%) | -454.42 | 34.72 | 59.21 | 123.39 | 308.38 | 9.46 | 35.45 | -23.41 | 808.52 | -84.77 | 174.11 |
| Debt/Equity(x) | 0.59 | 0.71 | 0.68 | 0.57 | 0.52 | 0 | 0.1 | 0 | 0.03 | 0.04 | 0.07 |
| Current Ratio(x) | 1.81 | 1.31 | 1.18 | 1.13 | 1.18 | 1.39 | 2.6 | 1.62 | 3.72 | 2.2 | 2.2 |
| Quick Ratio(x) | 0.35 | 0.26 | 0.37 | 0.31 | 0.32 | 0.54 | 1.7 | 1.02 | 2.83 | 1 | 0.63 |
| Interest Cover(x) | -3.13 | -2.32 | -0.12 | 1.3 | 2.89 | 7.32 | 10.66 | 9.48 | 39.19 | 25.15 | 49.19 |
| Total Debt/Mcap(x) | 0.84 | 0.97 | 0.56 | 0.49 | 0.26 | 0 | 0.1 | 0 | 0.02 | 0.03 | 0.05 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 51.17 | 51.17 | 51.17 | 51.17 | 51.17 | 51.17 | 51.32 | 51.35 | 51.37 | 51.37 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 |
| Public | 48.76 | 48.76 | 48.76 | 48.76 | 48.76 | 48.76 | 48.61 | 48.58 | 48.57 | 48.57 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.38 | 0.38 | 0.38 | 0.38 | 0.38 | 0.38 | 0.38 | 0.38 | 0.38 | 0.38 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.78 | 0.78 | 0.78 | 0.78 | 0.78 | 0.78 | 0.78 | 0.78 | 0.78 | 0.78 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +6% | +3% | +4% | +11% |
| Operating Profit CAGR | -5% | +64% | +12% | — |
| PAT CAGR | +167% | +59% | +32% | — |
| Share Price CAGR | -4% | +2% | +17% | +9% |
| ROE Average | +15% | +23% | +17% | +5% |
| ROCE Average | +23% | +37% | +29% | +15% |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 51.17 | 51.17 | 51.17 | 51.17 | 51.17 | 51.17 | 51.32 | 51.35 | 51.37 | 51.37 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 |
| Public | 48.76 | 48.76 | 48.76 | 48.76 | 48.76 | 48.76 | 48.61 | 48.58 | 48.57 | 48.57 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.38 | 0.38 | 0.38 | 0.38 | 0.38 | 0.38 | 0.38 | 0.38 | 0.38 | 0.38 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.78 | 0.78 | 0.78 | 0.78 | 0.78 | 0.78 | 0.78 | 0.78 | 0.78 | 0.78 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.